These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32112139)

  • 1. Vaginal recurrence of endometrial cancer: MRI characteristics and correlation with patient outcome after salvage radiation therapy.
    Steiner A; Alban G; Cheng T; Kapur T; Bay C; McLaughlin PY; King M; Tempany C; Lee LJ
    Abdom Radiol (NY); 2020 Apr; 45(4):1122-1131. PubMed ID: 32112139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas.
    Hasbini A; Haie-Meder C; Morice P; Chirat E; Duvillard P; Lhommé C; Delapierre M; Gerbaulet A
    Radiother Oncol; 2002 Oct; 65(1):23-8. PubMed ID: 12413671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer.
    Sapienza LG; Ning MS; de la Pena R; McNew LK; Jhingran A; Georgeon L; Rasool N; Gomes MJL; Abu-Isa E; Baiocchi G
    Int J Gynecol Cancer; 2020 Oct; 30(10):1535-1541. PubMed ID: 32376738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
    Ling DC; Vargo JA; Glaser SM; Kim H; Beriwal S
    Gynecol Oncol; 2019 Mar; 152(3):581-586. PubMed ID: 30600093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging response in patients treated with definitive radiation therapy for medically inoperable endometrial cancer-Does it predict treatment response?
    Gebhardt BJ; Rangaswamy B; Thomas J; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
    Brachytherapy; 2019; 18(4):437-444. PubMed ID: 31005602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
    Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal brachytherapy alone for patients with Stage II endometrial cancer with inner half cervical stromal invasion.
    Barnes EA; Parra-Herran C; Martell K; Barbera L; Taggar A; Leung E
    Brachytherapy; 2019; 18(5):606-611. PubMed ID: 31200993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
    Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
    Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
    Francis SR; Ager BJ; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
    Gynecol Oncol; 2019 Jul; 154(1):38-44. PubMed ID: 31029507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy.
    Jereczek-Fossa B; Badzio A; Jassem J
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):405-13. PubMed ID: 10974454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence.
    Petignat P; Jolicoeur M; Alobaid A; Drouin P; Gauthier P; Provencher D; Donath D; Van Nguyen T
    Gynecol Oncol; 2006 Jun; 101(3):445-9. PubMed ID: 16386785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
    Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
    Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.